miR‐199b‐5p directly targets PODXL and DDR1 and decreased levels of miR‐199b‐5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia
Open Access
- 20 January 2012
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 87 (4), 442-446
- https://doi.org/10.1002/ajh.23129
Abstract
Aberrant expression of Podocalyxin (PODXL), a CD34 orthologue, has been associated with acute myeloid leukemia (AML). Herein, via tissue microarray, we discovered elevated PODXL expression in M2, M4 and M1 FAB-subtype patients. Importantly, various investigations have linked aberrant miRNA expression with AML (1). A miRNA prediction algorithm identified PODXL as a conserved target for miR-199b, a significantly down-regulated miRNA in AML. Further prediction of miR-199b-5p targets identified Discoidin domain receptor 1 (DDR1) as another highly conserved target. For the first time, IHC analyses showed that DDR1 levels were also highly up-regulated in AML and more significantly, were elevated in the same AML cases where PODXL levels were increased. Experimental validation (via-mimics) confirmed that both PODXL and DDR1 are targets of miR-199b-5p. Furthermore, 3’UTR-luciferase assays established that miR-199b-5p targets PODXL and DDR1. Most importantly, we found significant decrease in miR-199b-5p levels in most AML patients with elevated PODXL and DDR1 expressions. Importantly, overexpression of miR-199b-5p in K562 cells caused significant decrease in collagen IV induced migration. Taken together, our studies have identified concurrent increased expression of PODXL and DDR1 in AML and directly connect decreased miR-199b-5p to these novel targets and potential antigomir-mediated therapeutic implications in AML.Keywords
This publication has 26 references indexed in Scilit:
- Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingCancer, 2011
- Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinaseOncology Reports, 2007
- Erythropoietin modulation of podocalyxin and a proposed erythroblast nicheBlood, 2007
- Podocalyxin Increases the Aggressive Phenotype of Breast and Prostate Cancer Cells In vitro through Its Interaction with EzrinCancer Research, 2007
- Acute myeloid leukaemiaThe Lancet, 2006
- Podocalyxin is expressed in normal and leukemic monocytesBlood Cells, Molecules, and Diseases, 2006
- Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2Journal of Neuro-Oncology, 2005
- PodocalyxinAmerican Journal of Clinical Pathology, 2005
- Discoidin Domain Receptor 1: A New Class of Receptor Regulating Leukocyte-Collagen InteractionImmunologic Research, 2005
- Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein PodocalyxinThe Journal of Experimental Medicine, 2001